NCT00543751TerminatedPhase 3
Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025)
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Status
- Terminated
- Sponsor
- Merck Sharp & Dohme LLC
- Enrollment
- 610
Study Overview
Brief Summary
The purpose of this study is to compare how MK0767 and metformin and sulfonylurea therapy lower blood glucose in patients with inadequate glycemic control This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 21 Years to 78 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with Type 2 diabetes wtih inadequate glycemic control on maximally effective/tolerated metformin and sulfonylurea therapy
- •Non-pregnant females
Exclusion Criteria
- •Patients with Type 1 Diabetes or history of ketoacidosis
- •Patients who have been treated with insulin or other antihyperglycemic agents
- •Patients with viral hepatitis, active liver or gallbladder disease, history of pancreatitis, heart disease, congestive heart failure, inadequately controlled hypertension, HIV positive, history hematologic disorders or neoplastic disease
Investigators
Similar Trials
Terminated
Phase 3
MK0767 and Sulfonylurea Combination Study (0767-027)Diabetes Mellitus, Type 2NCT00543491Merck Sharp & Dohme LLC129
Terminated
Phase 3
Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)Diabetes Mellitus, Type 2NCT00543361Merck Sharp & Dohme LLC382
Completed
Phase 4
Metformin to Prevent Metabolic Complications in Glucocorticoid ExcessPatients With Glucocorticoid TreatmentNCT01187849University Hospital, Basel, Switzerland29
Completed
Phase 4
Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and MetforminDiabetesNCT01099137Seoul National University Bundang Hospital344
Terminated
Phase 4
Effects of Metformin and Fish Oil on Treatment With ClozapineSchizo-affective DisorderSchizophreniaNCT02140788Duke University34